⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15471203 | 0.79 | KDM4E (0.38) | — | |
| SCHEMBL823836 | 0.78 | CA12 (0.44) | — | |
| SCHEMBL21578839 | 0.73 | — | — | |
| SCHEMBL12619778 | 0.73 | ALDH1A1 (0.39) | — | |
| SCHEMBL25928873 | 0.73 | ALDH1A1 (0.32) | — | |
| SCHEMBL24484928 | 0.73 | KDM4E (0.32) | — | |
| SCHEMBL99319 | 0.73 | ALDH1A1 (0.47) | — | |
| SCHEMBL12559211 | 0.71 | CA12 (0.44) | — | |
| SCHEMBL29580396 | 0.71 | CA12 (0.44) | — | |
| SCHEMBL1709354 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040121-B1 | NOVEL METHOD FOR PREPARING CYLOSPORIN DERIVATIVES | AVENTIS PHARMA (FR) | 2004-07-21 | — | — | EP | disclosed |
| EP-0951474-B1 | NOVEL CYCLOSPORIN DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | AVENTIS PHARMA SA (FR) | 2002-06-05 | — | — | EP | disclosed |
| EP-0948527-B1 | CYCLOSPORIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | AVENTIS PHARMA SA (FR) | 2002-06-05 | — | — | EP | disclosed |
| EP-1040121-A1 | NOVEL METHOD FOR PREPARING CYLOSPORIN DERIVATIVES | Aventis Pharma (FR) | 2000-10-04 | — | — | EP | disclosed |
| US-5994299-A | Cyclosporin compounds, their preparation and the pharmaceutical compositions which contain them | RHONE-POULENC RORER, S.A. (FR) | 1999-11-30 | — | — | US | disclosed |
| EP-0951474-A1 | NOVEL CYCLOSPORIN DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Aventis Pharma S.A. (FR) | 1999-10-27 | — | — | EP | disclosed |
| US-5965527-A | CYCLOSPORIN A SULFIDED AT THE 3 POSITION BY R-(CH)N-S-BY REACTING A LITHIUM-ACTIVATED DERIVATIVE WITH THE DISULFIDE; SYNERGISTIC MIXTURE WITH A RETROVIRUS VIRICIDE; SIDE-EFFECT REDUCTION; AIDS AND ARC (AIDS RELATED COMPLEX) | RHONE-POULENC RORER, S.A. (FR) | 1999-10-12 | — | — | US | disclosed |
| WO-1999032512-A1 | NOVEL METHOD FOR PREPARING CYLOSPORIN DERIVATIVES | AVENTIS PHARMA (FR) | 1999-07-01 | — | — | WO | disclosed |
| WO-1998028330-A1 | NOVEL CYCLOSPORIN DERIVATIVES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1998-07-02 | — | — | WO | disclosed |